Reducing Fetal Exposure to Maternal Depression to Improve Infant Risk Mechanisms
Depression
About this trial
This is an interventional treatment trial for Depression
Eligibility Criteria
Inclusion Criteria:
- Adult women (over 18 years of age)
- A singleton intrauterine pregnancy
- English speaking
- Elevated depressive symptoms based on screening with the Edinburgh Postnatal Depression Scale (EPDS) with score > 9
Exclusion Criteria:
- Bipolar disorder and psychosis based on the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-NP)
- Current psychotropic medication use or current CBT/IPT usage
- An HPA axis or an endocrine disorder
- Maternal substance use [assessed using maternal report and urine toxicology
- Corticosteroid medication use during this pregnancy
- Invitto fertilization
- Presence of cervical or uterine abnormalities
Sites / Locations
- University of DenverRecruiting
- University of Illinois
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Behavioral: Interpersonal Therapy
Enhanced Usual Care
Individual psychotherapy that includes an initial engagement session and a total of 8 sessions. IPT focuses on psychoeducation and interpersonal skill building to decrease interpersonal conflict and increase interpersonal support and competence.
Maternity support services (MSS) is the usual standard of care for pregnant women. A multi-disciplinary team of obstetric care providers routinely screen women for possible depression diagnosis. If a woman screens positive, she is seen by a behavioral health specialist (BHS) for further assessment and to initiate treatment, if necessary. The goals of MSS include offering services to promote healthy pregnancies and positive birth and parenting outcomes, including integrating mental health and prenatal care. Women with elevated depressive symptoms are seen by BHS throughout the pregnancy and postpartum period and then bridged to mental health treatment. BHS provides eclectic-based care but does not provide IPT.